GPT Healthcare is offering an Initial Public Offering (IPO) as a book-built issue worth Rs 525.14 crores. The IPO consists of a fresh issue of 0.22 crore shares amounting to Rs 40.00 crores and an offer for sale of 2.61 crore shares totaling Rs 485.14 crores.
Subscription for the GPT Healthcare IPO commences on February 22, 2024, and concludes on February 26, 2024. Allotment for the IPO is expected to be finalized on Tuesday, February 27, 2024. The shares of GPT Healthcare will be listed on both the BSE and NSE, with a tentative listing date set for Thursday, February 29, 2024.
The price band for the GPT Healthcare IPO is set at ₹177 to ₹186 per share. The minimum lot size for an application is 80 shares, requiring a minimum investment of ₹14,880 for retail investors. For sNII (non-institutional investors), the minimum lot size investment is 14 lots (1,120 shares), totaling ₹208,320, while for bNII (qualified institutional buyers), it is 68 lots (5,440 shares), amounting to ₹1,011,840.
Here’s how you can check the allotment status of GPT Healthcare IPO:
Step 1: Go to the BSE website.
Step 2: Choose ‘Equity’ and then the issue name from the selection menu.
Step 3: Enter your application number as well as your PAN card number and press ‘Search’.
You can also follow a similar procedure to check the allotment status on the Registrar’s website:
Step 1: Go to the Link Intime India website.
Step 2: Select the IPO name by clicking on ‘Company Selection’.
Step 3: Input your PAN, application number, DP/Client ID, or account number/IFSC number and click on ‘Search’.
If the details are input correctly, the status will appear only after allotment. The equity shares are expected to be credited to successful investors’ demat accounts on February 28, 2024
Established in 1989, GPT Healthcare Limited operates under the brand name ILS Hospitals, managing a network of mid-sized, multi-specialty hospitals primarily situated in Eastern India. Headquartered in Kolkata, West Bengal, the company specializes in delivering comprehensive healthcare services with a focus on secondary and tertiary care.
The hospital chain provides a wide array of medical services across more than 35 specialties and super-specialties. These include internal medicine, diabetology, nephrology (including kidney transplant procedures), laparoscopic and general surgery, gynaecology and obstetrics, intensive care, gastroenterology, orthopaedics and joint replacement, interventional cardiology, neurology, neurosurgery, paediatrics, and neonatology. Additionally, the company offers integrated diagnostic services and operates pharmacies within its facilities.
GPT Healthcare GMP
The GMP has not started yet.
